RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024

Rhea-AI Summary

RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company, has announced it will release its second quarter 2024 financial results on August 5, 2024, after market close. The company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss the results. Interested parties can register for the call, with a recommendation to join ten minutes early to ensure proper setup. A dial-in option will be available, and the call will be live-streamed and archived for one year on the company's investor relations website.

ALISO VIEJO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the second quarter of 2024 after the market close on Monday, August 5, 2024. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

To participate in the conference call please register here. While not required, it is recommended that participants join ten minutes prior to the event start time to ensure the necessary audio applications are downloaded and installed. Instructions are provided (including a dial-in option). The call will also be available live and archived for one year at https://investors.rxsight.com/.

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight^® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens^® (LAL™/LAL+™, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com

FAQ

When will RxSight (RXST) report its Q2 2024 financial results?

RxSight (RXST) will report its second quarter 2024 financial results on Monday, August 5, 2024, after the market close.

What time is RxSight's (RXST) Q2 2024 earnings conference call?

RxSight's (RXST) Q2 2024 earnings conference call is scheduled for August 5, 2024, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

How can I participate in RxSight's (RXST) Q2 2024 earnings call?

To participate in RxSight's (RXST) Q2 2024 earnings call, you need to register through the provided link. A dial-in option will be available, and it's recommended to join ten minutes prior to the start time.

Where can I access the archived version of RxSight's (RXST) Q2 2024 earnings call?

The archived version of RxSight's (RXST) Q2 2024 earnings call will be available for one year at https://investors.rxsight.com/.